⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002047073

Kadlec Robert Peter

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

7

Companies

1

Filings

6

CIK

0002047073

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-01	INKTMiNK Therapeutics, Inc.A Award	Director	AAward	+1,218 sh	$11.09	+$13.5K	19,126
2025-09-09	INKTMiNK Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,225 sh	—	—	3,225
2025-09-02	INKTMiNK Therapeutics, Inc.A Award	Director	AAward	+975 sh	$13.86	+$13.5K	17,908
2025-06-02	INKTMiNK Therapeutics, Inc.A Award	Director	AAward	+1,883 sh	$7.17	+$13.5K	4,647
2025-03-03	INKTMiNK Therapeutics, Inc.A Award	Director	AAward	+1,536 sh	$8.79	+$13.5K	2,764
2024-12-01	INKTMiNK Therapeutics, Inc.A Award	Director	AAward	+12.3K sh	$0.73	+$8,968.78	12,286
2024-10-30	INKTMiNK Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+41.7K sh	—	—	41,745

Recent filings

6

Accepted (ET)
Dec 34
Kadlec Robert Peter0001193125-25-306676
SEC(opens sec.gov)
Sep 114
Kadlec Robert Peter0001193125-25-201318
SEC(opens sec.gov)
Sep 34
Kadlec Robert Peter0001193125-25-195091
SEC(opens sec.gov)
Jun 44
Kadlec Robert Peter0000950170-25-081609
SEC(opens sec.gov)
Mar 54
Kadlec Robert Peter0000950170-25-033540
SEC(opens sec.gov)
Dec 94
Kadlec Robert Peter0000950170-24-134524
SEC(opens sec.gov)

Companies

1

MiNK Therapeutics, Inc.DirectorINKT

Address

149 FIFTH AVE., SUITE 500

NEW YORK, NY, 10010